Ideal Candidates for Factor VIII and Emicizumab for Hemophilia A

Video

Robert Sidonio, Jr., MD, MSc, discusses treatment considerations and ideal candidates for factor VIII and emicizumab in patients with hemophilia A.

Related Videos
Video 5 - "The Importance of Engaging Stakeholders When Implementing Bispecific Antibodies"
Video 4 - "Risk Evaluation Mitigation Strategy (REMS) Program Requirements for Bispecific Antibodies"
Video 3 - "Monitoring and Treating Adverse Events in Patients Receiving Treatment With a Bispecific Antibody"
Video 2 - "Key Considerations in Treatment Selection for Patients With Multiple Myeloma"
Video 1 - "Impact of Bispecific Antibodies on Multiple Myeloma Treatment"
© 2024 MJH Life Sciences

All rights reserved.